Both in Pharmaceuticals
Kyntra Bio vs Neuphoria Therapeutics
Over the past year KYNB returned −51.1% and NEUP returned −24.8%; their daily moves had a correlation of 0.13.
KYNB −51.1% NEUP −24.8%Growth of $1, one year, split-adjusted
| Metric | KYNB | NEUP |
|---|---|---|
| Price | $4.65 | $3.06 |
| Market cap | $18.8M | $16.6M |
| Today | −1.48% | −8.93% |
| 1 month | −30.1% | −14.0% |
| 6 months | −36.0% | −41.9% |
| Year to date | — | −21.1% |
| 1 year | — | −35.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $91.3M | — |
| Dividend yield | — | — |
| Volatility (60d) | 56.0% | 28.0% |
| Short % of float | 2.5% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).